HK1 and autosomal dominant polycystic kidney disease: Treatment with the mTOR inhibitor rapamycin (50 nM) reduced the enhanced mRNA expression of glycolytic genes (Hk1, Hk2, Pkm2) in ADPKD cells and also reduced the enhanced levels of lactate in the cell culture medium (Fig 7A–7D).